Literature DB >> 28068285

Vitamin K2 Improves Anxiety and Depression but not Cognition in Rats with Metabolic Syndrome: a Role of Blood Glucose?

Silvia M Gancheva1, Maria D Zhelyazkova-Savova1.   

Abstract

BACKGROUND: The metabolic syndrome is a socially important disorder of energy utilization and storage, recognized as a factor predisposing to the development of depression, anxiety and cognitive impairment in humans. AIM: In the present study we examined the effects of vitamin K2 on the behavior of rats with metabolic syndrome and looked for relationships with the effects on blood sugar.
MATERIALS AND METHODS: Male Wistar rats were divided in four groups: a control group on a regular rat chow, a metabolic syndrome (MS) group fed a high-fat high-fructose diet, a control group treated with vitamin K2 and a MS group treated with vitamin K2. Vitamin K2 was given by gavage. At the end of the study (after 10 weeks) behavioral tests were performed and fasting blood glucose was measured. Anxiety was determined using the social interaction test and depression was assessed by the Porsolt test. Memory effects were estimated by the object recognition test. Correlations between fasting blood glucose and behavioral performance were analyzed.
RESULTS: The rats from the MS group had elevated blood glucose. They had anxiety, depression and memory deficit. Vitamin K2 normalized blood glucose, reduced anxiety and depression, but did not improve memory. Time of social interaction (inverse index of anxiety) and memory recognition were negatively correlated with blood glucose in the untreated rats but the immobility time (measure of depression) was not. When vitamin K2-treated rats were added, the correlation of blood glucose with the time of social interaction was kept, but the one with the recognition memory was lost. It might be that the anxiolytic effect of vitamin K2 in this setting is at least partly due to its effects on blood glucose, while the anti-depressant effect is glucose-independent.
CONCLUSION: The present study demonstrated that vitamin K2 prevented the development of anxiety and depression, but did not improve the memory deficit caused by the dietary manipulation in an experimental model of metabolic syndrome. It might be that the anxiolytic effect of vitamin K2 is at least partly due to its effects on blood glucose, while the antidepressant effect is glucose-independent.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28068285     DOI: 10.1515/folmed-2016-0032

Source DB:  PubMed          Journal:  Folia Med (Plovdiv)        ISSN: 0204-8043


  8 in total

1.  Adherence to the dietary approaches to stop hypertension (DASH) dietary pattern and mental health in Iranian university students.

Authors:  Shiva Faghih; Siavash Babajafari; Afsaneh Mirzaei; Masoumeh Akhlaghi
Journal:  Eur J Nutr       Date:  2019-04-24       Impact factor: 5.614

2.  Association of Vitamin K Insufficiency as Evaluated by Serum Undercarboxylated Osteocalcin With Frailty in Community-Dwelling Older Adults.

Authors:  Kotaro Azuma; Yosuke Osuka; Narumi Kojima; Hiroyuki Sasai; Hunkyung Kim; Satoshi Inoue
Journal:  Front Aging       Date:  2022-04-13

3.  Relationship between Vitamin Intake and Depressive Symptoms in Elderly Japanese Individuals: Differences with Gender and Body Mass Index.

Authors:  Thao Thi Thu Nguyen; Hiromasa Tsujiguchi; Yasuhiro Kambayashi; Akinori Hara; Sakae Miyagi; Yohei Yamada; Haruki Nakamura; Yukari Shimizu; Daisuke Hori; Fumihiko Suzuki; Koichiro Hayashi; Hiroyuki Nakamura
Journal:  Nutrients       Date:  2017-12-03       Impact factor: 5.717

4.  Increased anxiety-like behavior is associated with the metabolic syndrome in non-stressed rats.

Authors:  Daniela Rebolledo-Solleiro; Gabriel Roldán-Roldán; Daniel Díaz; Myrian Velasco; Carlos Larqué; Guadalupe Rico-Rosillo; Gloria Bertha Vega-Robledo; Elena Zambrano; Marcia Hiriart; Miguel Pérez de la Mora
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

5.  The Relationship between Dietary Vitamin K and Depressive Symptoms in Late Adulthood: A Cross-Sectional Analysis from a Large Cohort Study.

Authors:  Francesco Bolzetta; Nicola Veronese; Brendon Stubbs; Marianna Noale; Alberto Vaona; Jacopo Demurtas; Stefano Celotto; Chiara Cacco; Alberto Cester; Maria Gabriella Caruso; Rosa Reddavide; Maria Notarnicola; Stefania Maggi; Ai Koyanagi; Michele Fornaro; Joseph Firth; Lee Smith; Marco Solmi
Journal:  Nutrients       Date:  2019-04-05       Impact factor: 5.717

6.  Effect of vitamin K2 administration on depression status in patients with polycystic ovary syndrome: a randomized clinical trial.

Authors:  Firoozeh Tarkesh; Bahia Namavar Jahromi; Najmeh Hejazi; Golazin Hoseini
Journal:  BMC Womens Health       Date:  2022-07-26       Impact factor: 2.742

7.  Metabolic syndrome-associated cognitive decline in mice: Role of minocycline.

Authors:  Aniruddha Mukherjee; Bina K Mehta; Kalyan K Sen; Sugato Banerjee
Journal:  Indian J Pharmacol       Date:  2018 Mar-Apr       Impact factor: 1.200

8.  Vitamin K2 (Menaquinone-7) Reverses Age-Related Structural and Cognitive Deterioration in Naturally Aging Rats.

Authors:  Hany A Elkattawy; Fatma M Ghoneim; Mohamed Ahmed Eladl; Eman Said; Hasnaa Ali Ebrahim; Mohamed El-Shafey; Saad Mohamed Asseri; Mohamed El-Sherbiny; Reem Hamoud Alsalamah; Nehal M Elsherbiny; Shimaa Hadhod
Journal:  Antioxidants (Basel)       Date:  2022-03-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.